Exhibit 99.2
預付權購買普通股
以美國存託憑證代表
團車網 有限公司
認股權證ADS:[________] | 原始發行日期:2024年十月[____] |
這份預先注資的購買認股權證 以美國存托股爲代表的普通股(”搜查令”) 證明,對於收到的價值,_____________ 或其分配(”持有者”)有權根據條款和行使限制和條件的約束 下文規定,在本協議發佈之日當天或之後的任何時候(”初始鍛鍊日期”)直到這個 認股權證已全部行使(”終止日期”)但此後不行,訂閱和購買 TuanChe 有限公司,開曼群島的一家公司(”公司”),最多 [______] 股普通股(”認股權證”) 由 [_______] 股美國存托股代表(”ADS”),視下文調整而定(”逮捕令 ADS”)。本認股權證下的一份認股權證ADS的購買價格應等於第節中定義的行使價 2 (b)。
第 1 部分. 定義。 此處使用但未另行定義的大寫術語應具有該特定證券購買協議中規定的含義 (”購買協議”),日期爲2024年10月 [____],由公司及其買方簽署。
第2節. 行權.
a) 行權 權證購股權的行使可以在初始行使日期以及終止日期之前的任何時間進行,可以全部或部分進行。通過電子郵件提交正式執行的PDF副本,按照補充附件中的行使通知的形式,將其發送給公司。在行使之日起,之前的兩個交易日或標準結算期所包含的交易日(如下所定義)內,持有人應通過電匯或美國銀行的已支票支取形式支付標明在適用的行使通知中的購股權股份的合計行使價款,除非適用的行使通知中指定了無現金行使程序。不需要墨水原件的行使通知,也不需要對行使通知進行任何證明保證(或其他類型的保證或公證)。儘管此處可能有任何相反的規定,但在持有人購買了此處可供的所有購股權股份並且購股權已全部行使的情況下,持有人在向公司交付最終的行使通知之後的三個交易日內,應向公司交付此購股權以便作廢。部分行使購股權將導致購買此處所提供的購股權股份的剩餘數量的減少,減少的數量等於購買的購股權股份的適用數量。公司和持有人應維護記錄,顯示購買的購股權股份數量和購買日期。公司應在收到行使通知後的一個交易日內提出任何異議。行使通知)。在(i)兩個(2)個交易日內或(ii)在行使日期後的標準交割期(如本節2(d)(i)中定義),持有人應通過電匯或美國銀行出具的現金支票支付購買的相關權證ADS的總行使價格,該價格在適用的行使通知中進行了規定,除非適用行使通知中規定了本節2(c)中規定的無現金行使程序。不需要墨水原件行使通知,也不需要任何典章擔保(或其他類型的擔保或公證)行使通知。儘管本協議有悖於此,但持有人在購買此處可獲得的全部權證ADS並且權證已完全行使之前不需要實際將本權證交還給公司,此時,持有人應在最終行使通知交付給公司之日起儘快將本權證交還給公司以便註銷。本權證的部分行使導致購買此處可獲得的權證ADS總數的一部分,將使可獲得的權證ADS數量下降,其數量等於購買的權證ADS數量。持有人和公司應保留記錄,顯示購買的權證ADS數量和購買日期。公司應在收到任何行使通知後的一個(1)個工作日內提出任何異議。 持有人和任何受讓人在接受本權證時,承認並同意,由於本段的規定,購買本文所述的一部分權證ADS之後,任何給定時間可購買的權證ADS數量可能會小於本權證正面所述的金額。
b)行使價格該認股權證的總行權價格除每個美國存托股憑證(ADS)0.001美元的領用價格外,在初始行使日期之前已經全部預先支付給了公司,因此,在任何行使該認股權證時,持有人無需向任何個人支付額外的考慮(除每個ADS 0.001美元的領用價格外)。持有人不得有權要求在任何情況或任何原因下返還或退還該預先支付的總行權價格的全部或任何部分,包括本認股權證在終止日期之前未行使的情況下。該認股權證下每個ADS的未支付行權價格爲0.001美元,應根據本協議進行調整(“行使價格”).
c) 無現金行權本權證可以在任何時間通過「免現金行使」方式行使,整體或部分行使 持有人有權獲得的權證ADS數量等於[(A-B) (X)] 除以 (A) 的商。其中:
(A) = 根據需要: (i) 如果相關行權通知的日期既不是美股盤中的交易日,也不是在此處根據第2(a)節執行和交付,而是在非美股盤中的交易日執行和交付,則爲該通知日前一個交易日的VWAP;或者是(i) 如果通知日在美股盤中的交易日在其開盤之前根據第2(a)節執行和交付,則爲該交易日之前一個交易日的VWAP,(ii) 持有人可選擇,要麼是(y) 通知日前一個交易日的VWAP,要麼是(z) 由彭博有限合夥公司報告的ADS在主要交易市場上的買盤價格。彭博社報道。''
(B) = 根據此處進行調整的本認股證的行權價格;和
(X) = 根據這個認股權協議的條款行使選項時由認購人承購的認股ADS的數量,如果該行權是以現金行權而不是無現金行權。
2
如果以無現金行使的方式發行ADSs,則各方承認並同意,根據證券法第3(a)(9)條的規定,ADSs將具有正在行使的認股權證的註冊特徵。公司同意不持有任何與本第2(c)部分相悖的立場。
“買盤價對於任何日期, 價格由適用的以下第一款條款確定:(a) 如果ADSs當時在一個交易市場上進行掛牌或報價,ADSs的買盤價格爲問題時的時間(或最接近的前一日期)在當時列出或報價的交易市場上由Bloomberg報告的(基於紐約市時間從上午9:30到下午4:02)(b) 如果OTCQb或OTCQX不是一個交易市場,該日期ADSs的成交量加權平均價格(或最近的前一日期)在OTCQb或OTCQX上適用,(c) 如果ADSs當時沒有在OTCQb或OTCQX上進行交易掛牌或報價,如果ADSs的價格當時報告在粉紅色公開市場上(或一個類似的機構或代理機構繼承報價職能),則將最近報告的ADSs的買盤價,或 (d) 在所有其他情況下,ADS的公平市場價值由一個由持有人中佔現有證券多數權益的誠信選擇獨立評估師確定,並且對公司合理接受的,其費用及開支應由公司支付。
“「VWAP」表示任何日期上任何證券的美元成交量加權平均價格,在納斯達克資本市場(或如果納斯達克資本市場不是該證券的主要交易市場,那麼在該證券的主要證券交易所或證券市場上,在該證券上從美國東部時間上午9:30開始,到美國東部時間下午4:00結束,在該證券上由彭博社通過其「VAP」功能報告的美元成交量加權平均價格(設置爲9:30開始時間和16:00結束時間);如果上述情況不適用,則爲在該證券的場外市場上,該證券的電子公告板在美國東部時間上午9:30開始,到美國東部時間下午4:00,在彭博社報告的美元成交量加權平均價格,或者如果沒有任何市場商報告該證券的美元成交量加權平均價格,則該證券市場製造商的最高收盤買入價與最低收盤賣出價的平均值從The Pink Open Market(或類似的機構或代理機構繼承其報告價格的功能)或其他方式獲得。如果無法計算該日期上該安全的VWAP,則該日期上該安全的VWAP將是我們和債券持有人共同確定的公平市場價值。如果我們和債券持有人無法就該證券的公平市場價值達成一致意見,那麼這種爭議應根據條款中規定的程序解決。對於所有這些決定應適當調整任何股票股利、股票分割、股票組合、資本重組或其他類似交易的加權平均價格。對於任何日期,"成交量" 指根據適用的以下第一個款規定的價格:(a) 如果ADS當時被列在或在交易市場上掛牌,ADS在該日期(或最接近的前一日期)的每日成交量加權平均價格,根據彭博有限合夥公司報告的該ADS於當天9:30 a.m.(紐約市時間)至4:02 p.m.(紐約市時間)的交易市場上掛牌或收盤報價(b) 如果OTCQB或OTCQX不是交易市場,則相應日期ADS的成交量加權平均價格(或最接近的前一日期)爲適用的OTCQB或OTCQX(c) 如果ADS當時未在OTCQB或OTCQX掛牌交易,並且如果ADS價格則在The Pink Open Market(或類似組織或機構繼任者報告價格的職能)報告,所報告的每股ADS的最新買盤價,或(d) 在其他所有情況下,ADS的公允市值由持有的突出證券權益中大部分投資者誠心誠意地選擇並且對公司合理可接受的獨立評估師所確定,其費用和支出應由公司支付。
除非有相反規定,否則在終止日期,本認股權將通過免現金行使根據本第2(c)條自動行使。
3
d) 鍛鍊的機理.
i. 在行使權證ADS時交付根據第(2)(a)款規定,在公司收到行使通知後,公司應通過紐約梅隆銀行,作爲ADS的存託人(「存託人」),將此處購買的權證股票轉讓給持有人,通過信貸持有人或其指定方的存款或提款託管系統(「DWAC」)的帳戶(如果公司當時是該系統的參與者並且(A)有一份有效的註冊聲明允許向持有人發行或轉售由權證ADS代表的權證股票或者(B)權證ADS代表的權證股票符合根據規則 144無 成交量或銷售方式限制而進行(假設權證無現金行使),否則通過在公司的股東登記簿中以持有人或其指定方的名義註冊的證書的物理交付,以便向持有人在行使通知中指定的地址交付持有人根據此次行使有權獲得的權證股票數量的時間,該日期晚於(i)交付行使通知之日後的兩個(2)個交易日,並且(ii)交付行使通知之日後的標準結算期包括的交易日數(該日期爲,“權證ADS交付日期),前提是在此類行使中(如果不是無現金行使的情況),在此類行使中,在此前交付了與此類行使有關的總行使價格(而且,如果在交付了此類行使的總行使價格(除無現金行使的情況下)的情況下未在該日期交付,其行使的權證ADS交付日期應晚於交付此類行使的總行使價格的兩 (2)個交易日)。在交付行使通知後,持有人應被視爲在權證已行使之日,就所有公司事務而言,無論權證ADS的交付日期如何,被視爲可以記錄的持有人 ,前提是總行使價格(如非無現金行使)在(i)兩(2)個交易日內及(ii)交付行使通知後的標準結算期包括的交易日數中 達成協議 交貨後接收。如果出於任何原因,存託人未能在權證ADS交付日期交付行使通知截至的權證ADS給持有人,公司應支付給持有人現金,作爲一種清償損害而非處罰,每1000美元的權證ADS的行使(基於適用行使通知日ADS的VWAP),每個交易日爲10美元(在第三個交易日後增加爲每個交易日20美元)爲了交付權證ADS交付截至之後的每個交易日,直至交付權證ADS或持有人撤銷該行使。公司同意繼續保持一個參與FASt計劃的過戶代理,只要本權證仍然有效並可行使。本合同中使用的“標準結算期「」代表公司在主要交易市場上的標準結算期,以交易日記數,關於有效行使通知書的交付日期。儘管前述,對於在初始行使日期前的交易日下午6點(紐約時間)交付的任何行使通知,這些通知可以在簽署購買協議後的任何時間交付,公司同意在Closing Date當天下午4點(紐約時間)以前交付涉及該通知的ADS,前提是在Closing Date之前收到總體行使價格的支付(除了無現金行使的情況)。
ii. 行使期權時,發行新的期權 。如果本期權被部分行使,公司應在持有人的請求和本期權證書的交割時,交付給持有人一份新的期權證明持有人購買本期權未購買的股票的權利,該新期權在其他方面與本期權完全相同。如果這份認股權證已經部分行使,公司應在持有人的要求並在交付認股權證ADS時交出這份認股權證,交付給持有人一份新的認股權證,證明持有人有權購買此認股權證要求購買但尚未購買的認股權證ADS,此新認股權證在其他方面應與本認股權證完全相同。
4
iii. 撤銷 權利如果公司未能導致託管人在權證ADS交付日期前按照第2(d)(i)款向持有人轉發權證ADS,那麼持有人將有權撤銷該行權,關於未轉發的權證ADS(效果是持有人對根據本權證應獲取的未轉發的權證ADS的權利將恢復),公司應將支付給公司的用於未轉發的權證ADS的合計行權價格部分退還給持有人。
iv. 補償 因未能及時交付認購權證ADS而引起的買入除了持有人享有的任何其他權利之外,如果公司未能按照上文第2(d)(i)條款規定按時交付認購權證ADS,導致持有人在認購權證ADS交付日期之前或之日以後在開放市場交易或其他方式下被其券商要求購買(或券商機構本身購買)ADS,以滿足出售已預期接受此類行權後收到的認購權證ADS的持有人的需求(「Buy-In」),則公司應(A)以現金支付持有人的金額,即持有人購買該ADS的總購買價格(包括券商佣金(如果有的話))超過(y)乘以(1)與有關訂單相關的公司應向持有人交付的認購權證ADS數量乘以(2)爲發出該購買要約的價格,根據持有人的選擇,(B)恢復未經遵守的部分認購權證和相應數量的認購權證ADS(在這種情況下,此次行使將被視爲撤銷),或向持有人交付認購權證的行使和交付義務下公司應當及時完成的ADS數量。例如,如果持有人購買的ADS的總購買價格爲11,000美元,以涵蓋與以總售價10,000美元提高此類購買義務的ADS的嘗試行使相關的買入,根據前文的條款(A),公司應支付持有人1,000美元。持有人應向公司遞交書面通知,指明應向持有人支付的補償金額,並應根據公司的要求提供相應損失的證據。本協議未限制持有人在此下追求任何其他可用於其的追索權,包括但不限於具體履行和/或具體表現命令,以針對公司未能按照本協議條款及時交付ADS而尋求法律救濟或衡平法救濟等權利。買入如公司未能向持有人交付所購買的ADSs(美國存托股票),則公司應按下列方式付款:(A)如持有人購買此類ADSs的總購買價格(包括券商佣金(若有))超過未交付ADSs數量與賣出訂單執行價格相乘得到的金額,則向持有人支付該差額現金,(B)持有人可以選擇恢復對等數量Warrant的部分,以補償未獲執行的Warrant ADSs,並返還公司收到的與這些Warrant ADSs有關的行權價金額(在這種情況下,行權應被視爲作廢),或向持有人交付ADSs,如果公司及時遵守了其根據本合同行使和交付義務應進行的行使,則將發出的ADSs數量交付給持有人。例如,如果持有人購買總購買價格爲11,000美元的ADSs,以支付約價10,000美元的Warrants嘗試行使引發的買入,那麼根據前述款項(A)的條款,公司應支付給持有人1,000美元。持有人應向公司提供書面通知,指示在買入方面應向持有人支付的金額,並在公司要求時提供損失金額的證據。本文中無論任何規定均不限制持有人依法根據此處可用的任何其他救濟措施,包括但不限於,要求公司按照本合同規定按時交付行使Warrant時應交付的ADSs的具體執行裁定和/或禁令救濟。
v. 不發行碎股或認股權證ADSs在行使本認股權證時不會發行任何認股權證ADSs的碎股。 關於持有人本應在行使中獲得購買的ADS的任何部分,公司可選擇 以等於該部分乘以行使價格的金額支付現金調整,或者 將其上調至下一個整數ADS;但是,如果將ADS的部分上調至下一個整數ADS導致發行價格低於ADS的票面價值,則不得進行上調。
5
vi. 收費、稅費和費用Warrant ADSs的發行將不收取持有人任何發行或轉讓稅或其他雜費,所有這些稅金和費用應由公司支付,這些Warrant ADSs將以持有人的姓名或持有人指定的姓名發行。 在每種情況下,該B類股東和/或該B類股東的家庭成員需獨立控制在此類帳戶、計劃或信託中持有的B類普通股實時;, 公司對於以下情況,不應承擔責任:根據第10(b)部分書面信息可靠地提供。在Warrant ADSs以非持有人姓名發行時,持有人在行使時需隨附附表有效執行的委託書,公司可能要求在此之際支付足夠的金額以補償其任何轉讓稅。公司應支付所有同日處理任何行使通知所需的託管費以及支付所有同日電子發行和交付Warrant ADSs給託管機構信託公司(或其他執行類似功能的建立的結算機構)所需的費用。公司將支付與此處Warrants ADSs發行相關的所有適用費用和託管公司的費用。
vii. 結賬 公司不會以任何方式關閉其股東名冊或記錄,以阻止根據本授權書及時行使權利;但是,前述情況不應被視爲或解釋爲限制存款人根據存款協議中的條款和規定所享有的任何權利。 包括但不限於,
e) 持有人的行使限制除非本協議另有規定,公司將不會行使本權證,持有人也無權行使本權證的任何部分,根據第2條或其他任何條款,如果經行使後根據適用行使通知所設定的情形後,持有人(連同持有人的關聯企業及任何其它與持有人或任何持有人的關聯企業一起行動的個人(該等人," 歸因方”)將超過有利權屬限制(如下所定義)。在上述句子的目的下,持有人及其關聯企業和歸因方所利益擁有的普通股數量將包括持有人及其關聯企業或歸因方實行情況確定是爲了行使本權證可發行的普通股ADSs條款下會產生的普通股數量,但將不包括普通股ADSs的數量,即(i)關聯方或歸因方持有的其餘、未行使部分的本權證實際佔有的數量,以及(ii)公司的未行使或未轉換部分,包括但不限於,受到類似於本協議中包含的限制的其它任何證券(例如,任何其它普通股等價物)的行使或轉換,由該等情況下的關聯方或歸因方實際佔有的數量。除前述句子所述外,根據本第2條(e)節的目的,有利權屬將根據《證券交易法》第13(d)條及其發出的規則和法規進行計算,持有人承認公司未向持有人保證此種計算是否符合《證券交易法》第13(d)條及持有人應負有依照法律要求的任何申報之計劃的唯一責任。在本第2條(e)節中適用的限制區間內,是否本權證可行使的確定(相對於由持有人連同其關聯企業及歸因方擁有的其它任何證券)以及本權證的哪部分可行使應由持有人個人決定,行使通知的提交將被視爲持有人對本權證是否可行使(相對於由持有人連同其關聯企業及歸因方擁有的其它任何證券)以及本權證的哪部分可行使的確定,均受有利權屬限制,並且公司無須核實或確認上述決定的準確性。此外,上述提到的任何組狀態的確定將根據《證券交易法》第13(d)條及其發出的規則和法規進行判定。在本第2條(e)節中,爲確定未發行的普通股數量,持有人可以依賴於反映在(A)公司最新的年度報告表20-F,提交給委員會的6-k報告或其他公開提交文件(如有)的普通股數量,(B)公司的最新公開聲明,或(C)公司或託管機構的最新書面通知報告的普通股已發行數量。在持有人的書面或口頭要求下,公司將在一個(1)個交易日內口頭和書面向持有人確認當時的普通股數量。在任何情況下,普通股的數量將在考慮到持有人或其關聯企業或歸因方自所報告的普通股數量截至日期以來在公司的證券,包括本權證的轉換或行使後被考慮的情況下確定。有益所有權限制。“應該是所發行普通股數立即之後 爲發行普通股票而行使本權證可行使的普通股數的[4.99%][9.99%]。持有人在通知公司時 可以增加或減少本第2(e)節中的受益所有權限制規定,前提是在任何情況下,受益所有權限制 不得超過習後立即發行的普通股數9.99%。普通股票持有人行使 本權證而持有的普通股數,並且本第2(e)節的規定應繼續適用。任何 受益所有權限制的增加將在此類通知交付後的第61天開始生效。本段規定應理解和實施,而不是嚴格符合 本第2(e)節的條款,以糾正本段(或本段的任何部分)可能存在的缺陷或與預期的 受益所有權限制不一致之處,或進行必要或有必要的變更或補充,以有效地實現 此類限制。本段規定中包含的限制應適用於本權證的繼任持有人。21世紀醫療改革法案 此自然 這些條款應以不與 本第2(e)節的條款嚴格一致的方式解釋和執行,以糾正本段(或其中的任何部分) 可能存在的缺陷或與擬議的所述 受益所有權限制不一致的原因,或進行必要或理想的變更或補充,以適當地實施上述 限制。本段所包含的限制應適用於本權證的繼任持有人。
6
第3章。資格.. 某些調整。.
a) 股票 紅利和拆分如果公司在本認股權證有效期內的任何時候:(i) 支付股息或以其他方式向其ADS或普通股或任何其他以ADS或普通股(其中,爲避免疑問,不包括公司行使本認股權證而發行的任何普通股或ADS)支付的股份進行分配或分配(ii)將未分割的普通股或ADS細分爲更多的普通股或ADS(iii)合併(包括通過逆向股份拆分)未分割的ADS或普通股爲更少的普通股或ADS,適用的,或(iv)通過重新分類ADS或普通股或公司的任何股份發行,則在每種情況下,行權價格將乘以一個分數,其中分子應爲該事件發生前立即發行的ADS數(不包括任何庫存股份),而分母應爲該事件發生後立即發行的ADS數,並且本認股權證行使後可以發行的股份數量將進行比例調整,以使本認股權證的行權價格總額保持不變。根據本第3(a)款所作的任何調整將在確定有權收到該股息或分配的股東的登記日期後立即生效,並在細分、合併或重新分類的情況下,在生效日期後立即生效。
b)保留.
c) 後續的權益發行除了根據上述第3(a)款進行任何調整外,如果公司在任何時候授予、發行或出售任何普通股等價物或者向ADS的記名持有人按比例提供購買權、認股權證、證券或其他財產(「股票」, 購買權那麼持有人將有權根據適用於此類購買權的條款,獲得持有人在爲授予、發行或出售此類購買權而進行記載持有ADS的持股享有權的日期前,完全行使本認股權所能獲得的總購買權,這不考慮本認股權的任何行使限制,包括但不限於有利所有權限制,或者,如果沒有爲授予、發行或出售此類購買權而進行記錄,那麼ADS的持有人確定的日期將被視爲有資格參與此類購買權的日期,出售此類購買權(在每種情況下,該B類股東和/或該B類股東的家庭成員需獨立控制在此類帳戶、計劃或信託中持有的B類普通股實時;, 公司對於以下情況,不應承擔責任:根據第10(b)部分書面信息可靠地提供。在這種情況下,如果持有人蔘與任何此類購買權的權利會導致持有人超過有益所有權限制,那麼持有人將不被授權在此種程度上(或者因此類購買權的有益所有權而持有ADS的有益所有權)參與此類購買權,並且此類購買權將被暫時保留,直到持有人有根據情況有資格參與該權利的時間,如果有的話,以免持有人超過有益所有權限制。
d) 按比例分配在本期權有效期內,如果公司宣佈或進行任何分紅或其他資產分配(或獲得其資產權利的持有者),以資本返還或其他形式(包括但不限於以現金、股票或其他證券、財產或期權的形式進行的分紅、股權分拆、重新分類、公司重組、安排計劃或其他類似交易)(「分紅」當期在發行本期權後的任何時間,如果公司宣佈或進行任何分紅或其他資產分配(或獲得其資產權利的持有者),以資本返還或其他形式(包括但不限於以現金、股票或其他證券、財產或期權的形式進行的分紅、股權分拆、重新分類、公司重組、安排計劃或其他類似交易),「則在每種情況下,持有人應有權以持有本期權完全行使後可獲得的ADS數量(不考慮任何行使限制,包括但不限於有益所有權限制)在分配中參與,而期權」。在記錄此類分配的日期之前,或者如果沒有記錄,則在規定參與此類分配的普通股或ADS記錄持有人的日期在每種情況下,該B類股東和/或該B類股東的家庭成員需獨立控制在此類帳戶、計劃或信託中持有的B類普通股實時;, 公司對於以下情況,不應承擔責任:根據第10(b)部分書面信息可靠地提供。在那種情況下,如果持有人蔘與任何該等分配的權利會導致持有人超過有益所有權限制,那麼持有人將不有權在該等程度上參與該等分配(或在任何普通股或ADS的有益所有權作爲該等分配的結果的任何程度上),且該等分配部分將被擱置,以持有人的利益,直至某種時機,如果有的話,其享有權益將不會導致持有人超過有益所有權限制的時候)
7
e) 基礎交易. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, exclusive license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Ordinary Shares (including any Ordinary Shares underlying the ADSs) are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Ordinary Shares or 50% or more of the voting power of the common equity of the Company (including any Ordinary Shares underlying the ADSs), (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Ordinary Shares or any compulsory share exchange pursuant to which the Ordinary Shares effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding Ordinary Shares (including any Ordinary Shares underlying the ADSs) or 50% or more of the voting power of the common equity of the Company (each a “基本交易”), occurs or is consummated, then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share represented by each Warrant ADSs that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of capital stock of the successor or acquiring corporation or of the Company, if the Company is the surviving corporation, and any additional consideration (the “備選補償作爲基本交易的結果,持有與此權證可行權之前所代表的權證股份數量的持有人 無需考慮本權證行使受到2(e)項的任何限制),可獲得應收賬款。爲了進行此類行使,行權價格的確定應進行適當調整, 以適用於基本交易中發行的替代對價的金額,基於每個普通股(包括ADSs下的任何權證股份)可發行的替代對價數量,並且公司應 以反映替代對價任何不同成分相對價值的合理方式分攤行權價格。如果普通股持有人對於在基本交易中收到的證券、現金或財產有 任何選擇權,則持有人在進行此類基本交易後行使本權證時應獲得相同的選擇權,以決定其獲得的替代對價。不論其他任何規定,在基本交易 發生時,公司或任何繼任實體(如下文所定義)均應根據持有人的選擇,在基本交易完成時(或者如果晚,則在適用基本交易的公開 宣佈日期後30天內)或隨時購買本權證,向持有人支付一個金額現金,等於該基本交易完成時本權證未行使部分的Black Scholes 價值(如下文所定義);在每種情況下,該B類股東和/或該B類股東的家庭成員需獨立控制在此類帳戶、計劃或信託中持有的B類普通股實時;, 公司對於以下情況,不應承擔責任:根據第10(b)部分書面信息可靠地提供。如果基本交易不在公司控制之內,包括未經公司董事會批准, 持有人僅有權從公司或任何繼任實體處收到相同類型或形式的對價(及按同等比例支付), 按照現金餘額的Black Scholes價值,該未行使部分的任何形式是否是現金、股票或任何二者的組合, 或者ADS持有人在基本交易中選擇按照可選的對價形式收到,投資者獲得相同的選擇權。 在每種情況下,該B類股東和/或該B類股東的家庭成員需獨立控制在此類帳戶、計劃或信託中持有的B類普通股實時;, 此外如果公司的ADS持有人在此類重大交易中沒有獲得或支付任何對價,則視爲這些ADS持有人在此類重大交易中收到了繼任實體的普通股(該實體可能是在此類重大交易後繼任的公司)。黑·斯科爾斯價值「」 表示根據從彭博終端的「OV」功能得出的基於Black-Scholes期權定價模型的本權證價值,該價值將於適用重大交易的完成日確定爲定價目的,並反映(A)美國國債利率對應的無風險利率,該利率持續時間等於適用重大交易的公告日期與終止日期之間的時間,(B)預期波動率等於(a)100%和(b)30天波動率、100天波動率或365天波動率中較大者,每個子句(1)-(3)均根據彭博終端的HVt功能(利用365天年化因子)於適用重大交易的公告後第一個交易日確定,(C)用於此類計算的每ADS的基礎價格應爲在適用重大交易的公告前一交易日(或適用重大交易的完成日(若較早))至持有人根據本第3條(e)的請求進行的交易日結束的期間內的最高成交均價,(D)剩餘期權期間等於適用重大交易的公告日期與終止日期之間的時間,以及(E)零借款成本。 Black Scholes價值的支付將通過即時可用資金的電匯(或其他對價)在(i)持有人選擇後的五個工作日內及(ii)基本交易完成日期後進行。公司將確保在基本交易中的任何繼任實體中,公司不是倖存方(“繼任實體根據本第3(e)條款的規定,根據股份持有人合理認可並經股份持有人(不得有不合理延遲)批准的書面協議,承擔在本權證和其他交易文件項下的所有義務,並在基礎交易前交付給股份持有人,用以換取本權證,標的基金安防-半導體的安全,實體的安全,以書面文件證明,並在形式和實質上與本權證相似,該安全可行使對應數量的這一安全的股份(或其母公司的實體)等於本權證下潛在的這一安全對應的權證股票的數量,這種權證股票可在基礎交易之前行使(不考慮本權證的任何行使限制),並且行使價格應將此處的行使價格應用於這些股份(但考慮到基礎交易中潛在的標的股票的相對價值和這些股份的價值,這些股份的數量和這一行使價格是爲了保護基礎交易發生之前本權證的經濟價值),並且在形式和實質上對股份持有人合理滿意。在發生任何這種基礎交易時,實體安防-半導體應被加入至本權證下的「公司」一詞(因此,自從此類基礎交易的發生或完成之日起,「公司」一文所指的每一款本權證和其他交易文件的條款應改爲代表公司和實體安防-半導體或實體安防-半導體,共同和分別),實體安防-半導體或實體安防-半導體與公司共同和分別,在此之前公司的每一個權利和權力均可行使,實體安防-半導體或實體安防-半導體應承擔在此之前公司在本權證和其他交易文件項下的所有義務,效力與在此處公司和實體安防-半導體或實體安防-半導體被單獨列爲公司時相同效果一樣。無疑地,無論(i)公司是否有足夠授權的普通股發行權證股份和/或(ii)是否在最初行使日期之前發生基礎交易,股份持有人都有權享受本3(e)條款的條款。
8
所有板塊計算。 所有計算均應四捨五入至最接近的一分錢或美國存托股份的1/100。就本第3節而言,在特定日期被認爲已發行並流通的普通股數量應爲已發行並流通的普通股數量之和(包括存托股份基礎的普通股,但不包括如有的庫藏股份)。
g) Notice to Holder.
i. Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant ADSs and setting forth a brief statement of the facts requiring such adjustment.
ii. Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Ordinary Shares or ADSs, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Ordinary Shares or ADSs, (C) the Company shall authorize the granting to all holders of the Ordinary Shares or ADSs rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification of the Ordinary Shares or ADSs, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Ordinary Shares are converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Ordinary Shares or ADSs of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Ordinary Shares (including Warrant Shares underlying Warrant ADSs) of record shall be entitled to exchange their Ordinary Shares for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Report on Form 6-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.
9
Section 4. Transfer of Warrant.
a) Transferability. Subject to applicable securities laws, this Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant ADSs without having a new Warrant issued.
b) New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be identical with this Warrant except as to the number of Warrant ADSs issuable pursuant thereto.
c) Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.
Section 5. Miscellaneous.
a) No Rights as Shareholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant ADSs on a “cashless exercise” pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.
b) Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant ADSs, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.
10
c) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.
d) Authorized Shares.
The Company covenants that, during the period the Warrant is outstanding, its directors will have authority to allot a sufficient number of shares to provide for the issuance of the Warrant ADSs and the underlying Ordinary Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the Warrant Shares needed for the Depositary to issue the necessary Warrant ADSs upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares and Warrant ADSs and the underlying Ordinary Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the applicable Trading Market upon which the ADSs and Ordinary Shares may be listed. The Company covenants that all Warrant ADSs and the underlying Ordinary Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant ADSs in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than any transfer restrictions and taxes in respect of any transfer occurring contemporaneously with such issue).
Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant ADSs above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant ADSs and the underlying Ordinary Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.
Before taking any action which would result in an adjustment in the number of Warrant ADSs for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.
11
e) Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.
f) Restrictions. The Holder acknowledges that the Warrant ADSs acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.
g) Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.
h) Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.
i) Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant ADSs, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any ADSs or Ordinary Shares or as a shareholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.
j) Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.
k) Depositary. For the avoidance of doubt, notwithstanding anything to the contrary contained herein, the Depositary’s rights and obligations with respect to the Company and the ADSs (including the Warrant ADSs) shall be as set forth in, and subject to, the terms and provisions of the deposit agreement among, inter alia, the Company and the Depositary and in no event shall this Warrant be deemed or construed to impose any additional obligations or liabilities on the Depositary, provided that this provision shall not limit in any respect the obligations of the Company under this Warrant.
l) Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant ADSs.
m) Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.
n) Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.
o) Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.
********************
(Signature Page Follows)
12
IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.
TUANCHE LIMITED | |||
By: | |||
Name: | |||
Title: |
13
NOTICE OF EXERCISE
To: TUANCHE LIMITED
(1) The undersigned hereby elects to purchase ________ Warrant ADSs of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.
(2) Payment shall take the form of (check applicable box):
☐ in lawful money of the United States; or
☐ if permitted, the cancellation of such number of Warrant ADSs as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant ADSs purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).
(3) Please register issue said Warrant ADSs in the name of the undersigned or in such other name as is specified below.
The Warrant ADSs shall be delivered to the following DWAC Account Number:
[SIGNATURE OF HOLDER]
Name of Investing Entity: |
Signature of Authorized Signatory of Investing Entity: |
Name of Authorized Signatory: |
Title of Authorized Signatory: |
Date: |
14
EXHIBIT B
ASSIGNMENT FORM
(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase Warrant ADSs.)
FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to
Name: | ||
(Please Print) | ||
Address: | ||
(Please Print) | ||
Phone Number: | ||
Email Address: | ||
Dated: ________________ __, ______ | ||
Holder’s Signature: ___________________ | ||
Holder’s Address: ____________________ |
15